Skip Navigation

A Phase II Trial of Perioperative CV301 Vaccination in Combination with Nivolumab and and Systemic Chemotherapy for Resectable Hepatic-Limited Metastatic Colorectal Cancer

Brief Summary

Type:
Colon

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03547999

Study #:
STUDY00144211

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03547999

View Complete Trial Details & Eligibility at ClinicalTrials.gov